Skip to main content
OpenTrials

Clinical trial condition

Liver Cirrhosis

Explore clinical trials studying Liver Cirrhosis. Study availability and eligibility vary by location and protocol.

167 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Liver Cirrhosis trial results

Active, not recruiting

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

NCT04526665

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The Institute for Liver Health Chandler, Arizona, United States
  • Keck Medical Center of USC Los Angeles, California, United States
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 115 locations
View Trial Details
Active, not recruiting

A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

NCT06730061

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Nippon Medical School - Chiba Hokusoh Hospital Chiba, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Chugoku Rosai Hospital Hiroshima, Japan
  • Teine Keijinkai Hospital Hokkaido, Japan
View all 16 locations
View Trial Details
Active, not recruiting

A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction

NCT07304843

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +11 more
Locations
  • University Hospital Düsseldorf Düsseldorf, Germany
  • University of Leipzig Leipzig, Germany
  • Hippokration General Hospital of Athens Athens, Greece
  • University Hospital of Patras Pátrai, Greece
View all 38 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

NCT05050136

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +16 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
View all 130 locations
View Trial Details
Active, not recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

NCT06174402

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The second hospital of Lanzhou University Lanzhou, Gansu, China
  • Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
  • Jiangsu Province Hospital Nanjing, Jiangsu, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details
Active, not recruiting

Linerixibat Long-term Safety, and Tolerability Study

NCT04167358

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +8 more
Locations
  • GSK Investigational Site Davis, California, United States
  • GSK Investigational Site West Hollywood, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Detroit, Michigan, United States
View all 94 locations
View Trial Details
Active, not recruiting

Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis

NCT06427395

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Zydus US013 Los Angeles, California, United States
  • Zydus US011 Pasadena, California, United States
  • Zydus US043 Sacramento, California, United States
  • Zydus US022 Aurora, Colorado, United States
View all 28 locations
View Trial Details
Active, not recruiting

Patients With Primary Biliary Cholangitis

NCT07573514

Conditions
Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +20 more
Locations
  • Fondazione Policlinico Universitaro A. Gemelli IRCSS,UOC Medicina Interna e Gastroenterologia,Largo A. Gemelli, Roma, Italy
View Trial Details
Active, not recruiting

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

NCT03301506

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Arkansas Diagnostic Center Little Rock, Arkansas, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • California Liver Research Institute Pasadena, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
View all 109 locations
View Trial Details

Related conditions